Cargando…
Serum 4β-hydroxycholesterol increases during fluconazole treatment
PURPOSE: The antifungal drugs ketoconazole and itraconazole reduce serum concentrations of 4β-hydroxycholesterol, which is a validated marker for hepatic cytochrome P450 (CYP) 3A4 activity. We tested the effect of another antifungal triazole agent, fluconazole, on serum concentrations of different s...
Autores principales: | Lütjohann, Dieter, Stellaard, Frans, Kerksiek, Anja, Lötsch, Jörn, Oertel, Bruno G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032583/ https://www.ncbi.nlm.nih.gov/pubmed/33201347 http://dx.doi.org/10.1007/s00228-020-03041-5 |
Ejemplares similares
-
Measurement of Serum Low Density Lipoprotein Cholesterol and Triglyceride-Rich Remnant Cholesterol as Independent Predictors of Atherosclerotic Cardiovascular Disease: Possibilities and Limitations
por: Lütjohann, Dieter, et al.
Publicado: (2023) -
The Interpretation of Cholesterol Balance Derived Synthesis Data and Surrogate Noncholesterol Plasma Markers for Cholesterol Synthesis under Lipid Lowering Therapies
por: Stellaard, Frans, et al.
Publicado: (2017) -
Serum Low Density Lipoprotein Cholesterol Concentration Is Not Dependent on Cholesterol Synthesis and Absorption in Healthy Humans
por: Stellaard, Frans, et al.
Publicado: (2022) -
Machine-learning-derived classifier predicts absence of persistent pain after breast cancer surgery with high accuracy
por: Lötsch, Jörn, et al.
Publicado: (2018) -
Influence of Chitosan Treatment on Surrogate Serum Markers of Cholesterol Metabolism in Obese Subjects
por: Lütjohann, Dieter, et al.
Publicado: (2018)